Following anesthesia and standard surgical preparation, an abdominal incision is made to directly visualize the liver. Ultrasound is performed to assess blood flow and localize each tumor to be treated. The radiofrequency needle electrode is then introduced into and around the lesion(s), and radiofrequency energy is delivered to ensure adequate tumor necrosis and tumor-free margins. Following successful ablation, the abdominal cavity is irrigated and hemostasis is confirmed. The incision is closed and dressed.
Following anesthesia and standard surgical preparation, an abdominal incision is made and a trocar is placed. The laparoscope is introduced so that the abdominal cavity can be directly visualized. A second incision is made and another trocar is placed laterally to the first incision and trocar. The laparoscopic ultrasound is then performed to visualize the liver and lesion(s) to be treated. The radiofrequency needle electrode is then introduced into and around the lesion(s) and radiofrequency energy delivered to ensure adequate tumor necrosis and tumor-free margins. Following successful ablation, the abdominal cavity is irrigated and hemostasis is confirmed. The trocars are removed and incisions closed and dressed.
After the patient is anesthetized, ground pads are applied to the patient’s thighs and, using one of three image guidance techniques (ultrasound, Computed Tomography (CT) or Magnetic Resonance (MR)), a radiofrequency needle electrode is passed percutaneously through the liver and into the tumor to be treated. Radiofrequency energy is then delivered to ensure adequate tumor necrosis and tumor-free margins. The number of ablative passes will depend on the number of tumors to be treated and the size of the tumors treated. The needle tract within the liver is usually embolized or cauterized with the ablation needle prior to its removal to minimize risk of bleeding.
- Safe and effective.
- Not experimental or investigational (exception: routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000, which meet the requirements of the clinical trials NCD are considered reasonable and necessary).
- Appropriate, including the duration and frequency that is considered appropriate for the service, in terms of whether it is:
- Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member.
- Furnished in a setting appropriate to the patient’s medical needs and condition.
- Ordered and furnished by qualified personnel.
- One that meets, but does not exceed, the patient’s medical need.
- At least as beneficial as an existing and available medically appropriate alternative.
Providers are reminded to refer to the long descriptors of the CPT codes in their CPT book. The American Medical Association (AMA) and the Centers for Medicare & Medicaid Services (CMS) require the use of short CPT descriptors in policies published on the Web.
Laparo ablate liver tumor rf
Laparo ablate liver cryosurg
Open ablate liver tumor rf
Open ablate liver tumor cryo
Percut ablate liver rf
Malignant neoplasm of liver, primary
Malignant neoplasm of intrahepatic bile ducts
Malignant neoplasm of liver, not specified as primary or secondary
Secondary malignant neoplasm of liver
Benign neoplasm of liver and biliary passages
Neoplasm of uncertain behavior, liver and biliary passages
Neoplasm of unspecified nature, digestive system